Capital expenditure increased 58.6%
Capital expenditure changed +58.6% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +58.6% from the comparable as-filed period.
Debt changed -98.6% from the comparable as-filed period.
Net income changed +150.7% from the comparable as-filed period.
Operating income changed +59.8% from the comparable as-filed period.
Operating margin changed +352 basis points from the comparable as-filed period.
Stock-based compensation changed -14.0% from the comparable as-filed period.
Capex / revenue changed +164 basis points from the comparable as-filed period.
Cash & equivalents changed -11.0% from the comparable as-filed period.
Selling, general & administrative changed -8.7% from the comparable as-filed period.
Gross margin changed -72 basis points from the comparable as-filed period.
Gross profit changed +1.4% from the comparable as-filed period.
Inventory changed +3.5% from the comparable as-filed period.
Revenue changed +3.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.